Last update 24 Jul 2025

CT-1190B

Overview

Basic Info

Drug Type
CAR-T
Synonyms
CT1190B CAR-T Cell
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [2]
Active Indication
Diffuse Large B-Cell LymphomaHigh grade B-cell lymphomaMediastinal large B-cell lymphoma+ [2]
Inactive Indication-
Originator Organization
Shanghai Tongji Hospital
Active Organization
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.Shanghai Tongji Hospital
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with CT-1190B
NCT06822881
/ RecruitingPhase 1
A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell Therapy, in Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
NCT06734871
/ RecruitingPhase 1IIT
A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell Therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
100 Clinical Results associated with CT-1190B
Login to view more data
100 Translational Medicine associated with CT-1190B
Login to view more data
100 Patents (Medical) associated with CT-1190B
Login to view more data
100 Deals associated with CT-1190B
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diffuse Large B-Cell LymphomaPhase 1
China
Shanghai Tongji Hospital
09 Jul 2025
High grade B-cell lymphomaPhase 1
China
Shanghai Tongji Hospital
09 Jul 2025
Mediastinal large B-cell lymphomaPhase 1
China
Shanghai Tongji Hospital
09 Jul 2025
Scleroderma, DiffusePhase 1
China
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
20 Feb 2025
Systemic Lupus ErythematosusPhase 1
China
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
20 Feb 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free